mild cognitive impairment
Initiatives being introduced in Taiwan, Hong Kong, and Singapore use AI and mobile technologies.
The app has demonstrated 93% accuracy in a nationwide study involving nearly 1,800 seniors.
Its developer, a spinoff from Nanyang Technological University, Singapore, is looking to raise up to $1.5 million to commercialise their MCI screening tool.
A clinical trial has shown that it can predict AD progression with 88% and 84% accuracy in American and Japanese patients, respectively.
The research project will be conducted using the Apple Watch and iPhone, and is set to begin during 2021.